Ubs Global Asset Management Americas »

Soleno Therapeutics shares owned by Ubs Global Asset Management Americas

Quarter-by-quarter ownership of Soleno Therapeutics (SLNO) shares owned by Ubs Global Asset Management Americas from 13F filings

Historical chart of Ubs Global Asset Management Americas investment in Soleno Therapeutics

May 2024Jul 2024Sep 2024Nov 2024Jan 20250.4M0.6M0.8M1M1.2M10k15k20k25k
Value ($)Share countHistorical SLNO position of Ubs Global Asset … Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Soleno Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Soleno Therapeutics by Ubs Global Asset Management Americas

Quarter filed Position value Share count Share price at filing
2024-12-31 $1.2M 28k 44.95
2024-09-30 $1.1M 22k 50.49
2024-06-30 $960k 24k 40.80
2024-03-31 $378k 8.8k 42.80

More positions owned by Ubs Global Asset Management Americas

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Tesla Motors (TSLA)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
UnitedHealth (UNH)
Visa Com Cl A (V)
JPMorgan Chase & Co. (JPM)
Mastercard Incorporated Cl A (MA)
Home Depot (HD)

View all positions for Ubs Global Asset Management Americas

Top funds holding Soleno Therapeutics

Vivo Capital
Henderson Group
Nantahala Capital Management
Adage Capital Partners GP
Susquehanna International
venBio Select Advisor
BlackRock
Vanguard Group
T. Rowe Price Associates
Perceptive Advisors
Carlyle
State Street Corporation
Citadel Advisors
Commodore Capital
Caption Management

View all funds holding Soleno Therapeutics